Go to the list of all blogs
Sergey Savastiouk's Avatar
published in Blogs
Feb 21, 2021
How to Tell the Difference Between Real and Fake A.I.

How to Tell the Difference Between Real and Fake A.I.

Artificial intelligence is here to stay. But as governments, companies, and people adapt to the reality of a world with AI, a revolutionary concept has been co-opted into a buzzword. AI as a sales tool has led to false claims and misinformation, making it difficult to parse facts about legitimate AI from the hype.

Here are some tips to help you tell the difference between real AI and fake AI.

AI is predicated on autonomy. It uses neural networks, machine learning, and other tools to create and run production models that not only simulate and predict outcomes, but act based on those predictions. Some analytics companies bill their services as AI-driven, but if a human is required to act on a recommendation made by AI, then it’s not real, independent AI. Useful AI removes the need for human intervention. Predictive technology alone is just that – predictive technology.

It is important to evaluate how much human input is required for an AI-driven platform. Human setup can (and should) be a part of each service – after all, someone needs to set the parameters that dictate AI’s behavior. But any platform requiring daily human operation or maintenance is not true AI. Services that necessitate lengthy training and consulting processes are not selling a truly automated experience.

Most companies offering legitimate AI products will contractually guarantee increased performance. Real AI operates at a level of efficiency that humans are not capable of, regardless of the task it is performing. Be wary of companies that cannot guarantee superior results relative to people or other products on the market. Insights alone are not a measure of useful AI – a service that does the work for you while also providing new levels of understanding is a legitimate AI product.

It is also vital to consider the transparency of the product in question. True AI tools will offer a window into the millions of tasks it performs – if actions are obscured or visible only to the company providing the service, chances are it is not useful AI. Paying for a service that could be a person and a tool performing the tasks that are billed as artificial intelligence defeats AI’s very purpose.

 

 

As more and more AI products and services hit the market, it will become increasingly important to identify real-deal offerings in a sea of pretenders. Real AI may be sculpted by humans, but it should perform at a level of efficiency – without any human input – that no human can approach.
 

Adding A.I. as a Tool in Your Investment Toolbox

One of the only certainties of investing in stocks, bonds, forex, cryptocurrency, or any other type of security is that there is no certainty when it comes to future price movements. Making an investment decision about a trade or a strategy can involve all the data and research in the world, but there still remains an element of chance, and ultimately, luck.

But that does not mean it’s a waste of time to perform diligent research and homework, and to use all of the tools at your disposal in an effort to make informed, smart decisions. More data generally leads to greater conviction, which can also also lead to a higher probability of success.

That’s where Artificial Intelligence comes in. It is a very new tool that until now has not been available on a broad basis to retail investors. The A.I. mentioned in this article can be found on Tickeron.com, and it offers investors a free trial. Tickeron’s idea is to provide retail investors with technology and tools to enable trading with massive amounts of data and analysis. The end result is arming retail investors with a high-powered, virtual research assistant: Tickeron’s Artificial Intelligence. Readers can check out the free trial here: Pattern Search Engine.


Contributor

Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.


Interact to see
Advertisement
During the week of 9–15 February 2026, major U.S. equity indices finished lower overall, while Tickeron’s trending AI trading bots produced positive returns, particularly in defense and energy—two areas now directly affected by the newly opened war in Iran. With macro risk rising and volatility picking up, this divergence matters: it shows how sector‑focused, rules‑based AI strategies can still find upside when broad index exposure is negative.
MRNA surged approximately +16.07% on March 4, 2026, closing at $57.84, up from the prior session's close of $49.83. The primary catalyst was Moderna's announcement of a landmark settlement in its long-running patent dispute over lipid nanoparticle (LNP) technology used in its mRNA vaccines.
Shares of The Trade Desk (TTD) surged +28.05% on March 5, 2026, reaching $32.23 from a prior close of $25.17. The primary catalyst was CEO Jeff Green's record insider purchase of approximately 6 million shares worth ~$148 million — the largest insider buy in the company's history.
AEO shares are trading at $19.89, down $2.56 or -11.40% from the prior session's close of $22.45. The primary catalyst is deeply disappointing Q1 fiscal 2026 operating income guidance of just $20–$25 million, which badly missed analyst expectations.
CIEN shares plunged 14.25% on March 5, 2026, trading at $294.59 versus the prior session's close of $343.55 — a decline of $48.96 per share. The steep sell-off came despite a strong earnings beat: adjusted EPS of $1.35 crushed the consensus estimate of $1.05 by 28.6%, and revenue of $1.43 billion rose 33% year-over-year.
Shares of Victoria's Secret & Co. (VSCO) tumbled approximately 11.87% in early trading on March 5, falling from a prior close of $60.01 to an intraday price near $52.89, with an intraday low of $51.61. The steep decline came despite a Q4 2025 earnings beat, with adjusted EPS of $2.77 topping the consensus estimate of $2.46 and revenue of $2.27 billion exceeding the expected $2.22 billion.
AMPX shares surged +18.57% in today's session, trading at $14.88 versus the prior close of $12.55. Primary catalyst: Q4 and full-year fiscal 2025 earnings, reported before the open, delivered a decisive beat on both EPS and revenue expectations.
EXPE shares are trading up approximately +9.70% intraday on March 5, 2026, rising from a prior close of $221.25 to around $242.71. March 5 is the stock's ex-dividend date for a newly raised quarterly dividend of $0.48 per share — a 20% increase from the prior payout — signaling strong management confidence in cash generation.
SES shares are down approximately 30% intraday on Thursday, March 5, 2026, trading near $1.19 against the prior session's close of $1.71. The primary catalyst is deeply disappointing 2026 revenue guidance of $30–$35 million — roughly 41% below the Wall Street consensus of $51.67 million.
What if a single trading robot could harvest volatility across semiconductors, oil, and communication technology — simultaneously — while filtering out the noise that burns most active traders? That's exactly what the Semiconductors, Oil & Energy, Communication Tech AI Trading Agent delivers. Over the past 364 days (March 5, 2025 – March 4, 2026), this agent generated a Total Net Profit of $20,641.78 on $500-per-trade sizing — an eye-catching Annualized Return of 68.58%. With 1,534 closed trades, a 61.86% win rate, and a dominant Profit Factor of 3.02
What if an AI trading agent could turn market chaos into a 45.55% annualized return? That's exactly what Tickeron's HUBB, AVGO, ITA, QQQ – AI Trading Agent (4 Tickers, 5min) has delivered across 106 days of live trading — posting $11,605.87 in total net profit from a per-trade allocation of $2,500–$8,250, a 69.59% win rate across 444 closed trades, and a Profit Factor of 2.18.
83.97% Win Rate | 87.10% Annualized Return | $44,879.15 Total Net Profit | Profit Factor: 4.92 | Sharpe Ratio: 1.13
HYMC’s latest sell‑off is part of a broader downtrend that accelerated after the company delayed its PEA, which investors interpreted as an uncertainty event despite no immediate change in reported resources or cash position. Technical indicators such as HYMC breaking above its upper Bollinger Band and then rolling over, along with the Aroon indicator turning down in late February, signaled an elevated risk of a sharp pullback that is now playing out.
DSGR reported quarterly EPS of about 0.18 dollars, badly missing consensus estimates of roughly 0.32–0.33 dollars per share and marking a sharp drop from 0.42 dollars a year ago, which triggered a large negative earnings surprise. Revenue of about 481–482 million dollars came in below expectations near 496 million dollars, and adjusted EBITDA margins compressed to about 7.4% from 9.3% in the prior‑year quarter, highlighting cost and mix pressures.
Shares of CRDO surged +11.90% on March 5, 2026, closing at $114.74 versus a prior close of $102.54. Primary catalyst: Strong Q3 fiscal 2026 earnings reported on March 2, with revenue of $407 million beating consensus estimates by more than $19 million and non-GAAP EPS of $1.07 surpassing forecasts by $0.29.
SPY is trading down approximately -1.30% in Friday premarket, slipping from the prior session's close of $681.31 to around $677–$678. The primary catalyst is a sharply negative February 2026 Nonfarm Payrolls report, which showed a decline of 92,000 jobs — a massive miss versus the consensus forecast of +50,000.
WAL shares dropped approximately 12% in early trading on March 6, 2026, from a prior close of ~$80.74 to roughly ~$71, marking one of the stock's sharpest single-session declines in recent months. The primary catalyst was a surprise announcement that Jefferies Financial Group declined to make a $126.4 million payment owed to Western Alliance Bank under a forbearance agreement tied to the LAM Trade Finance loan portfolio.
MRVL shares surged approximately +15% at the open on March 6, 2026, after closing at $75.68 the prior session. The primary catalyst was a strong Q4 fiscal 2026 earnings report released after the close on March 5, with non-GAAP EPS of $0.80 beating the $0.79 consensus estimate and revenue of $2.219 billion exceeding expectations.
Shares of Day One Biopharmaceuticals surged approximately +65.57% on March 6, 2026, rising from a prior close of $12.78 to an intraday price around $21.16. The primary catalyst driving the session's gains is acquisition and takeover speculation, with reports circulating that Day One may be a buyout target.
GAP shares fell approximately 13% in early trading on March 6, 2026, following the company's Q4 fiscal 2025 earnings report released after market close on March 5. Gap met Wall Street's Q4 estimates on both earnings per share and revenue, but fiscal 2026 guidance fell short of analyst expectations.
How to Tell the Difference Between Real and Fake A.I.